Svar Life Science

April 15, 2024

Upcoming Webcast - AAV safety and potency: exploring the analytical maze of gene therapy

GAIN A COMPREHENSIVE UNDERSTANDING OF AAV IMMUNOGENICITY ASPECTS 

Join our upcoming webcast presented by Nature Research Custom Media to learn:

  • Important aspects of AAV efficacy and potency
  • The significance, potential impact, and evaluation methods of the pre-existing humoral immune response to AAV vectors
  • Current challenges and approaches for the innate immune response in relation to AAV

REGISTER

April 15, 2024

Upcoming Webcast - AAV safety and potency: exploring the analytical maze of gene therapy

GAIN A COMPREHENSIVE UNDERSTANDING OF AAV IMMUNOGENICITY ASPECTS 

Join our upcoming webcast presented by Nature Research Custom Media to learn:

  • Important aspects of AAV efficacy and potency
  • The significance, potential impact, and evaluation methods of the pre-existing humoral immune response to AAV vectors
  • Current challenges and approaches for the innate immune response in relation to AAV

REGISTER

 

ARE YOU LOOKING TO DEVELOP OPTIMAL AAVS FOR GENE THERAPY?

In the rapidly expanding field of gene therapy, ensuring safety and efficacy remains a primary challenge. Immune responses against adeno-associated virus (AAV) capsids can impede the success of treatments.

In this webcast, you will gain valuable insights into the analytical aspects of immune responses and how they impact the potency, efficacy, and safety of AAV gene therapy.

EXCLUSIVE INSIGHTS FROM LEADING INDUSTRY EXPERTS

During the webinar,  Dr. Abraham Scaria, Chief Scientific Officer, Beacon Therapeutic; Dr. Nageswara Rao Kollu, Senior Director, Apellis; and Dr. Boris Gorovits, VP of non-clinical and clinical bioanalysis, Regeneron, will discuss current challenges and innovative approaches toward managing the innate immune response in the context of AAV gene therapy.

Seize this opportunity to be at the forefront of discussions to move this exciting field forward!

Engage in thought-provoking discussions with our experts during the interactive Q&A session

Don’t Miss Out – Register Today!

Can't make it live?
Register anyway to receive access on demand!

 

REGISTER